
AVITA Medical RCEL
$ 4.96
3.12%
Annual report 2025
added 02-12-2026
AVITA Medical DSO Ratio 2011-2026 | RCEL
Annual DSO Ratio AVITA Medical
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 53.2 | 55.2 | 40.7 | 35.2 | 67.9 | 62.2 | 141 | 1.66 K | 640 | 736 | 200 | 346 | 158 | 159 | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.66 K | 35.2 | 311 |
Quarterly DSO Ratio AVITA Medical
| 2025-Q3 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 56.3 | 58.7 | - | 44.4 | 47.4 | 60.6 | - | 38.9 | 39.8 | 34.7 | - | 37.3 | 40.3 | 39.9 | - | 42.8 | 30.7 | 28.1 | 38.5 | 40 | 37.1 | 18.7 | - | 19.7 | 26.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 60.6 | 18.7 | 39 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B | ||
|
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | ||
|
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M | ||
|
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | ||
|
Bruker Corporation
BRKR
|
57.3 | $ 38.5 | -1.96 % | $ 5.74 K | ||
|
Cognyte Software Ltd.
CGNT
|
72 | $ 8.19 | 4.73 % | $ 588 M | ||
|
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | ||
|
AdaptHealth Corp.
AHCO
|
43.8 | $ 9.67 | 2.87 % | $ 1.31 B | ||
|
InMode Ltd.
INMD
|
5.36 | $ 13.56 | -0.29 % | $ 876 M | ||
|
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | ||
|
EDAP TMS S.A.
EDAP
|
91.8 | $ 4.25 | 6.52 % | $ 158 M | ||
|
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | ||
|
CONMED Corporation
CNMD
|
64.5 | $ 42.99 | -0.01 % | $ 1.33 B | ||
|
Electromed
ELMD
|
137 | $ 24.29 | - | $ 205 M | ||
|
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | ||
|
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | ||
|
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | ||
|
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | ||
|
AxoGen
AXGN
|
40.7 | $ 29.22 | -2.04 % | $ 1.35 B | ||
|
Apyx Medical Corporation
APYX
|
85.8 | $ 3.3 | 4.1 % | $ 114 M | ||
|
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | ||
|
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | ||
|
Eargo
EAR
|
70.8 | - | - | $ 10.2 M | ||
|
FONAR Corporation
FONR
|
237 | $ 18.53 | 0.16 % | $ 121 M | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | ||
|
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | ||
|
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | ||
|
Accuray Incorporated
ARAY
|
69.7 | $ 0.52 | -0.67 % | $ 53.4 M | ||
|
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
120 | - | - | $ 111 M | ||
|
Cytosorbents Corporation
CTSO
|
68.6 | $ 0.79 | -1.25 % | $ 43 M | ||
|
Align Technology
ALGN
|
86.7 | $ 182.16 | - | $ 13.6 B | ||
|
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | ||
|
Butterfly Network
BFLY
|
76.1 | $ 4.03 | - | $ 853 M | ||
|
BIOLASE
BIOL
|
42 | - | -13.19 % | $ 166 K | ||
|
Abbott Laboratories
ABT
|
61.2 | $ 113.1 | - | $ 197 B | ||
|
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | ||
|
IRadimed Corporation
IRMD
|
56.8 | $ 105.11 | 0.79 % | $ 1.33 B | ||
|
Boston Scientific Corporation
BSX
|
65.7 | $ 72.21 | - | $ 107 B | ||
|
OrthoPediatrics Corp.
KIDS
|
74.3 | $ 18.48 | -1.02 % | $ 434 M | ||
|
IRIDEX Corporation
IRIX
|
45.6 | $ 1.41 | -1.4 % | $ 22.7 M | ||
|
Helius Medical Technologies
HSDT
|
53.3 | $ 2.31 | 16.67 % | $ 1.4 M | ||
|
Alphatec Holdings
ATEC
|
43.1 | $ 13.0 | - | $ 1.95 B | ||
|
Pulmonx Corporation
LUNG
|
54.9 | $ 1.44 | -5.88 % | $ 56.3 M | ||
|
Medigus Ltd.
MDGS
|
29.4 | - | 10.28 % | $ 55.5 M | ||
|
Medtronic PLC
MDT
|
68.8 | $ 95.6 | - | $ 123 B | ||
|
Edwards Lifesciences Corporation
EW
|
38.2 | $ 85.22 | - | $ 49.8 B |